BIOAGE LABS (BIOA) Investors with Losses are Encouraged to Contact BFA Law about Securities Class Action
New York, New York-- (Newsfile Corp. - February 1, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...
TCTMD20h
Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations
The IRA measure is a good first step, but some are looking even further ahead to GLP-1 price drops to increase access.
The Herald-Dispatch5h
Get the skinny on GLP-1 agonist medications
Achieving and maintaining a healthy weight is beneficial for a number of reasons. A healthy weight lowers a person’s chance ...
The Herald-Dispatch9h
Weight loss from GLP-1 agonists can lower risk of heart attack and stroke
GLP-1 agonists like Ozempic, Trulicity, Mounjaro, Victoza, Wegovy started as a way to treat diabetes but have since become popular for weight loss.
Earnings call transcript: AbbVie Q4 2024 beats expectations, shares rise
AbbVie provided an optimistic outlook for 2025, with an adjusted EPS guidance range of $12.12 to $12.32 and total net revenues expected to reach $59 billion. The company anticipates significant ...